We are a clinical-stage biopharmaceutical company focused on neuroscience. We translate novel scientific insights into new medicines. Similarly, What does...
sava stock
Cassava Sciences’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 5 Wall Streets Analysts....
Ownership Cassava Sciences Inc. The Vanguard Group, Inc. Similarly, Who owns anavex? Ownership Anavex Life Sciences Corp. The Vanguard Group,...
SAVA Stock Is Tremendously Undervalued And instead of estimating that 25% of America’s roughly 6 million Alzheimer’s patients will be...